Inhibition of DNase I Enzyme with Nickel(II) Triphenylphosphine Complexes Incorporating Tridentate Schiff Base Ligands in Vitro

Abstract

The nickel(II) complexes containing 3-methoxy-salicylaldehyde-N⁴-R thiosemicarbazones (R:-H₂,-propyl)with triphenylphosphine coligands have been synthesized. The structure of Ni(II)-centered metal complex was approved by elemental analysis and melting point. The solid-state structure of complex 2 bearing PPh₃ as co-ligand was clarified by single crystal X-ray crystallography, which revealed square planar geometry around Ni(II) ion. Thiosemicarbazone ligands are coordinated by ONS mode to nickel(II). The potential of these complexes to inhibit the DNase I enzyme, which uses DNA as a substrate, was investigated in vitro. The results revealed that the compounds inhibited the DNase enzyme in directly and/or indirectly (by masking of DNA molecules) at ≥0.1 µg/ml concentrations in vitro.

Keywords

• Nickel(II) complexes,thiosemicarbazones,X-ray crystallography,DNase I

References

1. 1. Lobana TS, Kumari P, Hundal G, Butcher RJ. Metal derivatives of N1-substituted thiosemicarbazones with divalent metal ions (Ni, Cu): Synthesis and structures. Polyhedron. 2010;29(3):1130-36.
2. 2. Padhye S, Kauffman GB. Transition Metal Complexes of Semicarbazones and Thiosemicarbazones. Coord. Chem. Rev.1985;63:127-60.
3. 3. Jiang ZG, Lebowitz MS, Ghanbari HA. Neuroprotective activity of 3 aminopyridine-2-carboxaldehydethiosemicarbazone (PAN-811), a cancer therapeutic agent. CNS Drug Rev. 2006;12(1):77-90.
4. 4. Güveli S, Kılıç-Cıkla I, Ülküseven B, Yavuz M, Bal-Demirci T. 5-Methyl-2-hydroxy-acetophenone-S-methyl-thiosemicarbazone and its nickel-PPh3 complex. Synthesis, characterization, and DFT calculations. J. Mol. Struct. 2018;1173:366-74.
5. 5. Ekennia AC, Onwudiwe DC, Ume C, Ebenso EE. Mixed ligand complexes of N-Methyl-N-phenyl dithiocarbamate: Synthesis, characterisation, antifungal activity, and solvent extraction studies of the ligand. Bioinorgan. Chem. Appl. 2015;2015:1-10.
6. 6. Güveli Ş, Bal-Demirci T, Ülküseven B, Özdemir N. Supramolecular nickel complex based on thiosemicarbazone. Synthesis, transfer hydrogenation and unexpected thermal behavior. Polyhedron. 2016;110: 188-96.
7. 7. Güveli S, Turan K, Ülküseven B. Nickel(II)-PPh3 complexes with ONS and ONN chelating thiosemicarbazones: synthesis and inhibition potential on influenza A viruses. Turk. J. Chem. 2018;42;371-84.
8. 8. Pahontu E, Fala V, Gulea A, Poirier D, Tapcov V, Rosu T. Synthesis and characterization of some new Cu(II), Ni(II) and Zn(II) complexes with salicylidene thiosemicarbazones: antibacterial, antifungal and in vitro antileukemia activity. Molecules. 2013;18(8):8812-36.

9. 9. Belicchi Ferrari M, Bisceglie F, Pelosi G, Sassi M, Tarasconi P, Cornia M, Capacchi S, Albertini R, Pinelli S. Synthesis, characterization and X-ray structures of new antiproliferative and proapoptotic natural aldehyde thiosemicarbazones and their nickel(II) and copper(II) complexes. J. Inorg. Biochem. 2002;90(3-4):113-26.
10. 10. Bal Demirci T, Congur G, Erdem A, Erdem-Kuruca S, Ozdemir N, Akgun-Dar K, et al. Iron(III) and nickel(II) complexes as potential anticancer agents: synthesis, physicochemical and structural properties, cytotoxic activity and DNA interactions. New J. Chem. 2015;39(7):5643-53.
11. 11. Umadevi C, Kalaivani P, Puschmann H, Murugan S, Mohana PS, Prabhakaran R. Substitutional impact on biological activity of new water soluble Ni(II) complexes: Preparation, spectral characterization, X-ray crystallography, DNA/protein binding, antibacterial activity and in vitro cytotoxicity. Journal of Photochemistry & Photobiology, B: Biology. 2017;167:45–57.
12. 12. Kalaivani P, Saranya S, Poornima P, Prabhakaran R, Dallemer F, Vijaya Padma V, Natarajan K. Biological evaluation of new nickel(II) metallates: Synthesis, DNA/protein binding and mitochondrial mediated apoptosis in human lung cancer cells (A549) via ROS hypergeneration and depletion of cellular antioxidant pool. Eur. J. Med. Chem. 2014;82:584-599.
13. 13. Prabhakaran R, Sivasamy R, Angayarkanni J, Huang R, Kalaivani P, Karvembu R, Dallemer F, Natarajan K. Topoisomerase II inhibition activity of new square planar Ni(II) complexes containing N-substituted thiosemicarbazones: Synthesis, spectroscopy, X-ray crystallography and electrochemical characterization. Inorg. Chim. Acta. 2011;374(1):647-653.
14. 14. Nadano D, Yasuda T, and Kishi K. Measurement of Deoxyribonuclease I Activity in Human Tissues and Body Fluids by a Single Radial Enzyme-Diffusion Method. Clin. Chem. 1993;39(3):448-52.
15. 15. Lazarides E, Lindberg U. Actin is the naturally occurring inhibitor of deoxyribonuclease I. Proc. Natl. Acad. Sci. U.S.A. 1974;71(6):4742-46.
16. 16. Baranovskii AG, Buneva VN, Nevinsky GA. Human deoxyribonucleases. Biochem. Mosc. 2004;69(6):587-601.
17. 17. Kolarevic A, Yancheva D, Kocic G, Smelcerovic A. Deoxyribonuclease inhibitors. European Journal of Medicinal Chemistry. 2014;88:101-11.
18. 18. Sheldrick G. SHELXS-97, Program for Crystal Structure Solution, Univ. Göttingen, Germany. 1997.
19. 19. Sheldrick GM SHELXL2014/1 Programs for the Solution and Refinement of Crystal Structures. University of Göttingen. 2014.
20. 20. Sheldrick GM. A short history of SHELX. Acta Crystallographica Section A Foundations of Crystallography. 2008;64(1):112–22.
21. 21. Sheldrick GM. University of Göttingen, Germany. 1996.
22. 22. Saint P. Bruker AXS Inc., Madison, Wisconsin, USA. 2012.
23. 23. Çağlayan E, Turan K. The effects of DNA methyl transferases on antiaging klotho gene expression. Turk. J. Biol. 2016;40(4):797-806.